D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

D. Boral Capital Initiates Coverage on MediciNova, Inc. (Nasdaq: MNOV)

D. Boral Capital, a leading global investment bank, is excited to announce that Jason Kolbert, our Managing Director of Healthcare Research, has initiated coverage on MediciNova, Inc. (Nasdaq: MNOV). This move underscores our dedication to delivering comprehensive analysis of innovative companies in the healthcare sector. Expert Analysis by Jason Kolbert: Jason Kolbert, our Managing Director… Continue reading D. Boral Capital Initiates Coverage on MediciNova, Inc. (Nasdaq: MNOV)